echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Climbing to the top, T-DXd brings new options for post-line treatment of HER2-positive advanced gastric cancer

    Climbing to the top, T-DXd brings new options for post-line treatment of HER2-positive advanced gastric cancer

    • Last Update: 2022-10-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    T-DXd changes the posterior treatment pattern


    * The medical community strives to be accurate and reliable in the review of its published content, but does not make any commitment or guarantee as to the timeliness of the published content and the accuracy and completeness of the cited materials (if any), nor does it assume any liability



    Click "Read the original article" to see more information

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.